These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

927 related items for PubMed ID: 18421790

  • 21. The mechanism of osteoclast differentiation induced by IL-1.
    Kim JH, Jin HM, Kim K, Song I, Youn BU, Matsuo K, Kim N.
    J Immunol; 2009 Aug 01; 183(3):1862-70. PubMed ID: 19587010
    [Abstract] [Full Text] [Related]

  • 22. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
    Yi T, Lee HL, Cha JH, Ko SI, Kim HJ, Shin HI, Woo KM, Ryoo HM, Kim GS, Baek JH.
    J Cell Physiol; 2008 Nov 01; 217(2):409-22. PubMed ID: 18543257
    [Abstract] [Full Text] [Related]

  • 23. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD, Kim HN, Lee JH, Jin WJ, Hwang SJ, Kim HH, Ha H, Lee ZH.
    Biochem Pharmacol; 2013 Sep 15; 86(6):782-90. PubMed ID: 23928189
    [Abstract] [Full Text] [Related]

  • 24. Enhanced osteoclastogenesis in 4-1BB-deficient mice caused by reduced interleukin-10.
    Shin HH, Lee JE, Lee EA, Kwon BS, Choi HS.
    J Bone Miner Res; 2006 Dec 15; 21(12):1907-12. PubMed ID: 17002586
    [Abstract] [Full Text] [Related]

  • 25. Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos.
    He L, Lee J, Jang JH, Lee SH, Nan MH, Oh BC, Lee SG, Kim HH, Soung NK, Ahn JS, Kim BY.
    Bone; 2012 Jun 15; 50(6):1207-13. PubMed ID: 22484180
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts.
    Ikeda F, Matsubara T, Tsurukai T, Hata K, Nishimura R, Yoneda T.
    J Bone Miner Res; 2008 Jun 15; 23(6):907-14. PubMed ID: 18251700
    [Abstract] [Full Text] [Related]

  • 30. Infection-induced up-regulation of the costimulatory molecule 4-1BB in osteoblastic cells and its inhibitory effect on M-CSF/RANKL-induced in vitro osteoclastogenesis.
    Saito K, Ohara N, Hotokezaka H, Fukumoto S, Yuasa K, Naito M, Fujiwara T, Nakayama K.
    J Biol Chem; 2004 Apr 02; 279(14):13555-63. PubMed ID: 14729681
    [Abstract] [Full Text] [Related]

  • 31. The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-κB in collagen-induced arthritis and bone marrow-derived macrophages.
    Huh JE, Jung IT, Choi J, Baek YH, Lee JD, Park DS, Choi DY.
    Eur J Pharmacol; 2013 Jan 05; 698(1-3):57-66. PubMed ID: 22985747
    [Abstract] [Full Text] [Related]

  • 32. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway.
    Sato K, Suematsu A, Nakashima T, Takemoto-Kimura S, Aoki K, Morishita Y, Asahara H, Ohya K, Yamaguchi A, Takai T, Kodama T, Chatila TA, Bito H, Takayanagi H.
    Nat Med; 2006 Dec 05; 12(12):1410-6. PubMed ID: 17128269
    [Abstract] [Full Text] [Related]

  • 33. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
    Amcheslavsky A, Hemmi H, Akira S, Bar-Shavit Z.
    J Bone Miner Res; 2005 Sep 05; 20(9):1692-9. PubMed ID: 16059640
    [Abstract] [Full Text] [Related]

  • 34. A novel small molecule, NecroX-7, inhibits osteoclast differentiation by suppressing NF-κB activity and c-Fos expression.
    Kim HJ, Yoon KA, Lee MK, Kim SH, Lee IK, Kim SY.
    Life Sci; 2012 Nov 02; 91(19-20):928-34. PubMed ID: 23000100
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.
    Tsuji-Naito K.
    Bioorg Med Chem; 2008 Oct 15; 16(20):9176-83. PubMed ID: 18823786
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.